Fatty acid synthase (FASN) overexpression caused resistance to GEM-based therapy in PDA, and it directly regulated PKM2 expression and glucose metabolism, leading to GEM chemoresistance in PDA cells [191]. This evidence concerns the gene PKM and Patent ductus arteriosus.